Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma

被引：0

作者：

Kaedbey, Rayan ^{[1
]}

Hay, Kevin ^{[2
]}

Masih-Khan, Esther ^{[3
]}

Kardjadj, Moustafa ^{[4
]}

McCurdy, Arleigh ^{[5
]}

Chu, Michael P. ^{[6
]}

Jimenez-Zepeda, Victor H. ^{[7
]}

Leblanc, Richard ^{[8
]}

Song, Kevin ^{[9
,10
]}

Mian, Hira S. ^{[11
]}

Louzada, Martha L. ^{[12
]}

Sebag, Michael ^{[13
]}

Reiman, Anthony ^{[14
]}

White, Darrell J. ^{[15
,16
]}

Venner, Christopher P. ^{[17
,18
]}

Stakiw, Julie ^{[19
]}

Kotb, Rami ^{[20
]}

Aslam, Muhammad ^{[21
]}

Bergstrom, Debra ^{[22
]}

Gul, Engin ^{[23
]}

Reece, Donna E. ^{[24
]}

机构：

[1] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada

[2] British Columbia Canc Res Inst, Terry Fox Lab, Vancouver, BC, Canada

[3] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

[4] Canadian Myeloma Res Grp, Toronto, ON, Canada

[5] Ottawa Hosp, Dept Med, Div Hematol, Ottawa, ON, Canada

[6] Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada

[7] Univ Calgary, Tom Baker Canc Ctr, Dept Hematol, Calgary, AB, Canada

[8] Hop Maison Neuve Rosemont, Montreal, PQ, Canada

[9] Univ British Columbia, Div Hematol, Vancouver, BC, Canada

[10] Vancouver Gen Hosp, Leukemia BMT Program BC, Vancouver, BC, Canada

[11] McMaster Univ, Dept Oncol, Hamilton, ON, Canada

[12] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada

[13] McGill Univ, Div Hematol, Hlth Ctr, Montreal, PQ, Canada

[14] St Johns Hosp, Oncol, St John, NB, Canada

[15] Dalhousie Univ, Halifax, NS, Canada

[16] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[17] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada

[18] Univ British Columbia, Vancouver, BC, Canada

[19] Saskatoon Canc Ctr, Saskatoon, SK, Canada

[20] CancerCare Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada

[21] Allan Blair Canc Ctr, Regina, SK, Canada

[22] Mem Univ Newfoundland, Div Hematol, St John, NL, Canada

[23] Univ Hlth Network PMH, Concord, ON, Canada

[24] Princess Margaret Canc Ctr, Toronto, ON, Canada

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-163661

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10002 / 10004

页数：3

共 50 条

[21] Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma
Fiala, Mark A.
Vosuri, Venkata
Goldsmith, Scott
Schroeder, Mark A.
Ghobadi, Armin
Wildes, Tanya M.
Stockerl-Goldstein, Keith E.
Vij, Ravi
BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1188 - 1190
[22] Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma
Mark A. Fiala
Venkata Vosuri
Scott Goldsmith
Mark A. Schroeder
Armin Ghobadi
Tanya M. Wildes
Keith E. Stockerl-Goldstein
Ravi Vij
Bone Marrow Transplantation, 2020, 55 : 1188 - 1190
[23] Second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma: Improved outcomes in patients with longer disease free interval after first autologous stem cell transplantation
Mikhael, J
Samiee, S
Stewart, AK
Chen, C
Trudel, S
Franke, N
Winter, A
Phillips, D
Reece, D
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 117 - 117
[24] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
Marek Hus
Norbert Grzasko
Marta Szostek
Andrzej Pluta
Grzegorz Helbig
Dariusz Woszczyk
Maria Adamczyk-Cioch
Dariusz Jawniak
Wojciech Legiec
Marta Morawska
Justyna Kozinska
Piotr Waciński
Anna Dmoszynska
Annals of Hematology, 2011, 90 : 1161 - 1166
[25] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
Hus, Marek
Grzasko, Norbert
Szostek, Marta
Pluta, Andrzej
Helbig, Grzegorz
Woszczyk, Dariusz
Adamczyk-Cioch, Maria
Jawniak, Dariusz
Legiec, Wojciech
Morawska, Marta
Kozinska, Justyna
Wacinski, Piotr
Dmoszynska, Anna
ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1161 - 1166
[26] Salvage Allogeneic Hematopoietic Cell Transplantation for Relapsed or Progressive Multiple Myeloma After Autologous Hematopoietic Cell Transplantation
Schneidawind, Dominik
Oehrlein, Katharina
Weisel, Katja C.
Faul, Christoph
Kanz, Lothar
Bethge, Wolfgang A.
BLOOD, 2012, 120 (21)
[27] Third Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
Garnett, Catherine
Giles, Chrissy
Lasa, Maialen
Ahmed, Osman
Bua, Marco
Auner, Holger W.
MacDonald, Donald
Marks, Sasha
Marin, David
Milojkovic, Dragana
Pavlu, Jiri
Abdalla, Saad
Kanfer, Edward J.
Apperley, Jane
Rahemtulla, Amin
BLOOD, 2012, 120 (21)
[28] Second autologous stem cell transplant (ASCT) as salvage therapy for relapsed multiple myeloma.
Olin, RL
Porter, DL
Luger, SM
Schuster, SJ
Tsai, D
Nasta, S
Perl, A
Loren, AW
Goldstein, S
Glatstein, E
Siegel, DL
Vogl, DT
Mangan, P
Cunningham, K
Stadtmauer, EA
BLOOD, 2005, 106 (11) : 342A - 342A
[29] Autologous Stem Cell Transplantation Is an Effective Salvage Therapy for Primary Refractory Multiple Myeloma
Parrish, Christopher
Rahemtulla, Amin
Cavet, Jim
Pearce, Rachel M.
Kirkland, Keiren
Lee, Julia
Cook, Mark
Wilson, Keith
Cook, Gordon
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (07) : 1330 - 1334
[30] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma.
Grosskreutz, CL
Egan, R
Scigliano, E
Fruchtman, SM
Isola, LM
BLOOD, 2003, 102 (11) : 489B - 490B

← 1 2 3 4 5 →